ERBB2 and triple-negative breast carcinoma: The classic subtyping, based on estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status, includes ER+HER2−, HER2+, and triple-negative breast cancer (TNBC).